STOCK TITAN

CRWV Insider Notice: 63,230 RSU Shares to Be Sold on 09/11/2025

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filing a Form 144 notifies a proposed insider sale of 63,230 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $7,289,772.07 and an approximate sale date of 09/11/2025 on NASDAQ. The shares were acquired as restricted stock units (compensation) and dated 09/11/2025 with payment listed as compensation. The filing also records a prior sale by Nitin Agrawal of 6,010 shares on 08/20/2025 for $540,858.66. The signer represents no undisclosed material adverse information.

Positive

  • None.

Negative

  • Proposed sale of 63,230 Class A shares valued at $7,289,772.07 scheduled for 09/11/2025 via Morgan Stanley Smith Barney
  • Insider disposition activity includes a prior sale of 6,010 shares on 08/20/2025 for $540,858.66

Insights

TL;DR: Insider plans to sell ~63k shares (RSUs) worth $7.29M; prior small sale recorded.

The notice documents a proposed Rule 144 sale of 63,230 Class A shares acquired as restricted stock units and scheduled for 09/11/2025 via Morgan Stanley Smith Barney. The filing is procedural, meeting disclosure requirements for resale of recently vested compensation shares. The prior sale of 6,010 shares on 08/20/2025 for $540,858.66 is disclosed, showing recent insider disposition activity. From a capital-markets perspective, this is a material-sized single transaction in absolute dollars but the filing provides no information on insider intent, company performance, or lock-up constraints.

TL;DR: Rule 144 notice documents compliance for sale of compensation shares; disclosure aligns with securities rules.

The Form 144 presents the mechanics of a proposed sale: acquisition date, nature (RSUs/compensation), broker, and aggregate market value. The signer explicitly represents that they lack undisclosed material adverse information, a standard attestation. The document lacks additional governance context such as a 10b5-1 plan adoption date or beneficial ownership details, so governance implications are limited to routine compliance disclosure.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CoreWeave (CRWV) Form 144 filed here disclose?

The Form 144 discloses a proposed sale of 63,230 Class A common shares (acquired as RSUs) with an aggregate market value of $7,289,772.07, approximate sale date 09/11/2025, and prior sale details of 6,010 shares on 08/20/2025 for $540,858.66.

Who is the broker handling the proposed sale in the filing?

The broker listed for the proposed sale is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY.

How were the shares being sold acquired according to the Form 144?

The 63,230 shares were acquired on 09/11/2025 as restricted stock units (compensation), with payment characterized as compensation.

Does the filing state any undisclosed material information about CoreWeave operations?

By signing, the person represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.

What prior insider sale is reported in this Form 144?

A sale by Nitin Agrawal of 6,010 Class A shares on 08/20/2025 is reported, generating gross proceeds of $540,858.66.

Is there any information about a 10b5-1 trading plan in the filing?

The filing includes the standard attestation regarding 10b5-1 plans but does not provide a 10b5-1 plan adoption date or other plan details.